POLYMAXTPE ANNOUNCES LABORATORY LINE EXPANSION

POLYMAXTPE ANNOUNCES LABORATORY LINE EXPANSION 

PolymaxTPE announced a $400,000 capital investment to the company’s research and development and production capabilities. This investment to the Waukegan, IL, facility will help PolymaxTPE increase its efficiency and support of the North American market. Delivered to PolymaxTPE this year, the new additions are highlighted by a Coperion ZSK Mc¹⁸ twin-screw compounding extruder, an ECON underwater pelletizing EUP system, as well as other auxiliary equipment. “PolymaxTPE continues to raise the bar on product innovation and customer service with this investment in the North American facility,” said Tom Castile, vice president of sales at PolymaxTPE. “The expansion increases our ability to create better solutions faster and is representational of our commitment to maintaining the status of a recognized, world-class organization.” During the COVID-19 pandemic, many companies have been forced to adjust, having to learn how to do more with less, which requires new processes, systems and materials to be constantly evaluated. Arriving at the perfect time, the addition of the new laboratory line will result in PolymaxTPE delivering an even faster response to customers, according to the company. “In this challenging economy, customers have a stronger need for shorter lead times,” said Castile. “PolymaxTPE was already well-positioned to serve these customers, but with the new line, we will increase our efficiency to fulfill requests. Customers can expect the same consistency and quality as we help them to better adjust to the current landscape of the industry.” With the added research and development capabilities brought on by this line, PolymaxTPE will continue to expand the Maxelast brand, as well as its A-Series and P-Series product lines that serve the medical markets. It will also support the strong surge of re-shoring efforts that continues across the industry.